注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Acorda Therapeutics Inc是一家生物製藥公司。該公司致力於開發能恢復神經系統疾病患者功能和改善其生活的療法。該公司使用其ARCUS肺部輸送系統,這是一個技術平台,旨在通過吸入輸送藥物,用於開發各種吸入藥物。該公司的產品包括INBRIJA(左旋多巴吸入粉)和AMPYRA(dalfampridine)。INBRIJA是一種吸入左旋多巴(L-dopa),用於間歇治療間歇發作,也就是用carbidopa/左旋多巴方案治療的帕金森病患者的間歇期。INBRIJA利用其ARCUS平台進行吸入療法。AMPYRA(dalfampridine)是達法普利定的一種緩釋片製劑,用於治療多發性硬化症(MS)患者的步行。Ampyra由Biogen International GmbH在美國境外以“Fampyra”的名義銷售。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Ron Cohen | 67 | 1995 | Founder, CEO, President & Director |
Sandra Panem | 76 | 1998 | Independent Director |
John P. Kelley | 69 | 2008 | Independent Non-Executive Chairman |
Thomas M. Burns | 49 | 2023 | Independent Director |
Michael S. Beattie | - | - | Member of Scientific Advisory Board |
Stephen G. Waxman | - | - | Member of Scientific Advisory Board |
Mary B. Bunge | - | - | Member of Scientific Advisory Board |
James W. Fawcett | - | - | Member of Scientific Advisory Board |
Eugene M. Johnson | - | - | Member of Scientific Advisory Board |
Carl W. Cotman | 84 | - | Member of Scientific Advisory Board |
Jerry Silver | - | - | Member of Scientific Advisory Board |
Jacqueline C. Bresnahan | - | - | Member of Scientific Advisory Board |
Patrick A. Tresco | - | - | Member of Scientific Advisory Board |
Mark Tuszynski | - | - | Member of Scientific Advisory Board |
Melitta Schachner | - | - | Member of Scientific Advisory Board |
Peder K. Jensen | 69 | 2011 | Independent Director |
John W. Varian | 64 | 2022 | Independent Director |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核